About Mitofam
Add Pedigree
Help
About Mitofam
Add Pedigree
Help
MT-COX1
A6307G
A6474G
A7222G
A7222G-F1
A7299G
A7445C
A7445G
A7445G-F6
A7445G-F5
A7445G-F4
A7445G-F7
A7445T
C6328T
C6489A
C6489A-F1
C6597A
C6597A-F1
G5906A
G5913A-F1
G5913A
G5920A
G6261A
G6480A
G6480A-F1
G6579A
G6708A
G6955A
G6962A
G7023A
G7444A
G7444A-F21
G7444A-F9
T6459C
T6459C-F1
T6526C
T6547C
T6721C
T6742C
G6930A
Edit by Mitofam Team
-
+
首页
A6307G
# **General Information** | **Position** | **6307** | **Variant** | **m.6307A\>G** | **Locus** | **MT\-CO1** | **Amino\-AcidChange** | **N135S** | | --- | --- | --- | --- | --- | --- | --- | --- | | **Homoplasmy** | . | **Heteroplasmy** | \+ | **APOGEE2** | Likely\-benign | **Pathogenicity** | Reported | "Pathogenicity" status is derived from published literature or predictions from bioinformatics tools. Researchers and clinicians are cautioned that additional data and/or analysis may still be necessary to confirm the pathological significance of these variants. For more information, please see [Mitofam Info](https://mitofam.com/doc/385/). # **Pedigree Information** The **m.6307A\>G** variant in MT\-CO1 has been reported in 6 pedigrees. To date, 6 carriers have been reported. Reported mutation loads ranged from 98%, with a median of 98% overall; affected carriers showed mutation loads from 98%, with a median of 98%. The main clinical manifestations among affected carriers included asthenozoospermia and male infertility. | **No.** | **Position** | **Variant** | **Family ID** | **Nationality** | **Diseases** | **Unaffected Maternal Relatives** | **Affected Maternal Relatives** | **Publication Year** | **PMID/Ref** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 6307 | m.6307A\>G | A6307G\-F1 | Tunisian | Asthenozoospermia; male infertility | ND | ND | 2013 | [23712756](https://pubmed.ncbi.nlm.nih.gov/23712756/) | | | 2 | 6307 | m.6307A\>G | A6307G\-F2 | Tunisian | Asthenozoospermia; male infertility | ND | ND | 2013 | [23712756](https://pubmed.ncbi.nlm.nih.gov/23712756/) | | | 3 | 6307 | m.6307A\>G | A6307G\-F3 | Tunisian | Asthenozoospermia; male infertility | ND | ND | 2013 | [23712756](https://pubmed.ncbi.nlm.nih.gov/23712756/) | | | 4 | 6307 | m.6307A\>G | A6307G\-F4 | Tunisian | Asthenozoospermia; male infertility | ND | ND | 2013 | [23712756](https://pubmed.ncbi.nlm.nih.gov/23712756/) | | | 5 | 6307 | m.6307A\>G | A6307G\-F5 | Tunisian | Asthenozoospermia; male infertility | ND | ND | 2013 | [23712756](https://pubmed.ncbi.nlm.nih.gov/23712756/) | | | 6 | 6307 | m.6307A\>G | A6307G\-F6 | Tunisian | Asthenozoospermia; male infertility | ND | ND | 2013 | [23712756](https://pubmed.ncbi.nlm.nih.gov/23712756/) | | # **Carrier Information** | **No.** | **Position** | **Variant** | **Family ID** | **Carrier ID** | **Type (Fam/De novo/Uninf)** | **Gender (F/M)** | **Proband (Y/N)** | **Affected (Y/N)** | **Die/Alive(D/A)** | **Age** | **Blood Mutant Level** | **Muscle Mutant level** | **Urine Mutant level** | **Other Mutant level** | **Clinical Features** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 6307 | m.6307A\>G | A6307G\-F1 | A6307G\-F1\-P1 | Uninf | M | Y | Y | ND | ND | / | / | / | 98%(Sperm) | Asthenozoospermia; male infertility | | | 2 | 6307 | m.6307A\>G | A6307G\-F2 | A6307G\-F2\-P1 | Uninf | M | Y | Y | ND | ND | / | / | / | 98%(Sperm) | Asthenozoospermia; male infertility | | | 3 | 6307 | m.6307A\>G | A6307G\-F3 | A6307G\-F3\-P1 | Uninf | M | Y | Y | ND | ND | / | / | / | 98%(Sperm) | Asthenozoospermia; male infertility | | | 4 | 6307 | m.6307A\>G | A6307G\-F4 | A6307G\-F4\-P1 | Uninf | M | Y | Y | ND | ND | / | / | / | 98%(Sperm) | Asthenozoospermia; male infertility | | | 5 | 6307 | m.6307A\>G | A6307G\-F5 | A6307G\-F5\-P1 | Uninf | M | Y | Y | ND | ND | / | / | / | 98%(Sperm) | Asthenozoospermia; male infertility | | | 6 | 6307 | m.6307A\>G | A6307G\-F6 | A6307G\-F6\-P1 | Uninf | M | Y | Y | ND | ND | / | / | / | 98%(Sperm) | Asthenozoospermia; male infertility | | For abbreviations and other usage instructions, please see [Mitofam Info](https://mitofam.com/doc/385/).
Haoying Chen
2026年6月26日 16:21
转发
收藏文档
上一篇
下一篇
手机扫码
复制链接
手机扫一扫转发分享
复制链接
分享
链接
类型
密码
更新密码
有效期
Markdown文件
Word文件
PDF文档
PDF文档(打印)